Niamh Madigan | 01/22/2013
TxCell is a biotechnology company founded in 2001. This Biotech is dedicated to the development of therapeutic products for severe chronic inflammatory and autoimmune diseases with high unmet medical needs, including inflammatory bowel and joint diseases and neurological diseases such as Multiple Sclerosis.
One of the main challenges the compnay faced was the shipment and final preparation of medication as well as making them adaptable to larger populations, the products...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More